1955-46-0COC(=O)c1cc(C(=O)O)cc([N+](=O)[O-])c1ZCRNIIJXDRYWDU-UHFFFAOYSA-N1955-46-0DTXSID50883784Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 37.5% (3 of 8) of reports.
Warning
H302 (12.5%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 8 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
REACH registered substance: Methyl 5-nitrohydrogen.isophthalate (EC: 217-793-6)
1,3-Benzenedicarboxylic acid, 5-nitro-, monomethyl ester: Does not have an individual approval but may be used under an appropriate group standard
Usesmono-Methyl 5-nitroisophthalate has been used as starting reagent in the synthesis of 3-amide-5-[(dipropylamino)carbonyl]benzoic acids.
UsesMethyl 5-nitroisophthalate is used in the preparation of heterotrifunctional crosslinkers for multiple bioconjugation with peptides and also in the synthesis of histone demethylase LSD1 inhibitors tha t target cancer cells.